Posts

Vol.8 No.4 – 2:Non-invasive follow-up of Egyptian patients infected with Helicobacter pylori by quantification of H. pylori circulating antigen in serum using ELISA

By: Hager R. Fawzy1, Asmaa M. Abdelmageed2, Mahmoud A. Shoulkamy1, Mohamed Abdel Wahab2, Hisham Ismail3, *

1Microbiology Division, Botany & Microbiology Dept., Faculty of Science, Minia University, Minia 61519, Egypt

2Gastrointestinal Surgery Center, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt

3Biochemistry Division, Chemistry Dept., Faculty of Science, Minia University, Minia 61519, Egypt.

Abstract

Clinicians still wish to determine if H. pylori-infected patients have been cured after specific treatment. The present study aimed to evaluate the reliability of the H. pylori circulating antigen (HpCAg) test for noninvasive screening of H. pylori infection and assessment of cure after specific treatment. Sera of 134 symptomatic individuals (81 males & 53 females, aged 23-68 yr) were screened for HpCAg using ELISA. H. pylori infection was confirmed using a gold standard based on culture, rapid urease test, and histology testing. The detection rate of HpCAg was 69% among screened individuals. The gold standard confirmed H. pylori infection in 93% of individuals showing HpCAg in their sera. In addition, 31% of infected patients were excluded for their drug resistance. Eligible individuals received a standard triple therapy regimen including Lansoprazole, Clarithromycin, and Amoxicillin twice daily for 14 days. Six weeks later, the HpCAg testing was repeated to evaluate the treatment outcome. HpCAg was not detected in 78 % of treated individuals. Furthermore, the levels of HpCAg were significantly decreased (p < 0.001) in the sera of non-responders. In conclusion, the detection of HpCAg is a reliable non-invasive approach for screening and follow-up of H. pylori-infected individuals after treatment, especially in developing countries.

Non-invasive-follow-up-of-Egyptian-patients-infected-with-Helicobacter-pylori-by-quantification-of-H.-pylori-circulating-antigen-in-serum-using-ELISA

Download PDF

Vol.4 No.4 – 17 : Evaluation of circulating antigen in urine technique for diagnosis of Schistosoma haematobium infection

By : Ahmed Abdelhalim Yameny

Society of Pathological Biochemistry and Hematology, Egypt

Ahmed A. Yameny (Email: dr.ahmedyameny@yahoo.com)

DOI: 10.21608/jbaar.2018.155494

Abstract

Background : Diagnosis of urinary and intestinal schistosomiasis by detecting circulating Schistosome antigens in serum and urine have been developed and assessed to dissolve problems with parasitological diagnosis in low endemic areas or for early diagnosis, this study aimed to evaluate commercially available kit, using circulating antigen in urine as alternative for microscopic testing of urine to diagnose S.haematobium infection Subjects and methods: This study is a cross-sectional study designed to evaluate circulating antigen a commercially available kit was used for determine urinary schistosomiasis  in the study population, this performed on 50 positive S.haematobium samples and 50 negative samples for individuals matching in age and sex , in addition, urine microscopic examination was done for detection of S.haematobium eggs by sedimentation centrifugation and nuclepore filteration techniques. Results :  The results showed that circulating antigen kit in urine had a sensitivity of 56% and specificity of 76%.. PPVs was 70% whereas NPVs was 63.3 %. As for diagnostic efficiency, it was 66%, where the area under the curve (AUC) was sufficient 0.63 . Conclusion and Recommendations: Years ago this commercial kit used in our study and in all medical laboratories in Egypt for detection of schistosome antigen in urine is called schistofast bilharzial antigen in urine , this study showed low sensitivity (56%) and lowe specificity (76) than expected resuls for detection of circulating antigen and they are generally more expensive than microscopic examination.


Evaluation of circulating antigen in urine technique for diagnosis of schistosoma haematobium infection-converted

Download PDF